BCR-ABL1 Transcript ≤10% IS an Early Molecular Response Predictor of Treatment-Free Remission Eligibility in Chronic Myeloid Leukemia. - Rasekh, Eman O.; Sherif, Menna M.; Ibrahim, Nagwa; Ibraheem, Dalia; Ghareeb, Mohamed; Elfishawi, Sally (Clinical Lymphoma, Myeloma & Leukemia, 2026)